Suven Life Sciences LtdHealthcare Research- Analytics and TechnologyINE495B01038Consolidated₹341.55-8.30 (-2.37%)Jun-26
Valuation
Market Cap₹9.65K Cr
TTM PE-22.94x
Forward PE-22.45x
PEG-1.15
Book Value₹20.93
P/B16.32x
TTM EPS₹-14.89
Fwd EPS₹-15.21
TTM Revenue₹8.82 Cr
TTM PAT₹-352.44 Cr
TTM EBITDA₹-366.24 Cr
TTM EBIT₹-372.65 Cr
Last Qtr PAT₹-127.61 Cr
Last Qtr EBITDA₹-132.49 Cr
Last Qtr EBIT₹-134.65 Cr
Profitability
ROE-59.59%
ROCE-28.37%
TTM NPM-3995.92%
TTM EBITDA %-4152.38%
Curr OPM-1150.68%
Last OPM-549.40%
Curr NPM—
Last NPM—
Curr EPS₹-4.84
Last EPS₹-2.02
Balance sheet
Equity₹26.37 Cr
Reserve₹565.03 Cr
Total Debt₹16.93 Cr
D/E0.03x
Interest %-0.38%
Curr Interest₹0.48 Cr
Price / range
Close₹341.55
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-2.37%
1W-3.94%
1M+0.49%
3M+31.52%
6M+147.68%
1Y+56.03%
2Y+119.01%
3Y+359.63%
5Y+296.46%
Diwali+106.81%
Sector peers — Healthcare Research- Analytics and Technology
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits